Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Dermatology

Date Submitted: Apr 27, 2021
Open Peer Review Period: Apr 19, 2021 - Jun 14, 2021
Date Accepted: Jul 17, 2021
Date Submitted to PubMed: Aug 26, 2023
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Comparing Risk Profiles in Critical Care Patients With Stage 2 and Deep Tissue Pressure Injuries: Exploratory Retrospective Cohort Study

Alderden J, Amoafo L, Zhang Y, Fife C, Yap D, Yap T

Comparing Risk Profiles in Critical Care Patients With Stage 2 and Deep Tissue Pressure Injuries: Exploratory Retrospective Cohort Study

JMIR Dermatol 2021;4(2):e29757

DOI: 10.2196/29757

PMID: 37632818

PMCID: 10334951

Comparing Risk Profiles in Critical Care Patients with Stage 2 versus Deep Tissue Pressure Injuries: An Exploratory Retrospective Cohort Study

  • Jenny Alderden; 
  • Linda Amoafo; 
  • Yue Zhang; 
  • Caroline Fife; 
  • David Yap; 
  • Tracey Yap

ABSTRACT

Background:

Understanding hospital-acquired pressure injury (HAPrI) etiology is essential for developing effective preventive interventions. Pressure injuries (PrI) are classified based on the degree of visible tissue damage; the two most commonly identified HAPrI stages in critical care patients are stage 2 and deep tissue injury (DTI). Some experts speculate stage 2 and those considered a DTI have different etiology, with stage 2 being formed from the "outside-in" as a result of tissue deformation, decreased perfusion, and subsequent ischemia caused by external pressure and/or shear forces, whereas the DTI emerges from the "inside-out" due to inadequate perfusion to the deeper tissues causing tissue ischemia.

Objective:

The purpose of this short report is to compare risk profiles of ICU patients who developed stage 2 versus DTI HAPrIs.

Methods:

This was a retrospective cohort study of ICU patients' risk factor profiles comparing stage 2 and DTI HAPrI using electronic health record (EHR) data. Eligible patients were admitted to the surgical ICU or cardiovascular ICU at an academic medical center in the United States between 2014 and 2018. Risk profile variables included demographic characteristics, Braden Scale scores, vasopressor infusions, hypotension, surgical factors, length of stay, body mass index, laboratory values, diabetes, Charleston Comorbidity Index, and the levels of sedation or agitation. The distributions of potential risk variables between patients with stage 2 and DTI HAPrI were summarized and compared. A logistic regression model with the Least Absolute Shrinkage and Selection Operator (LASSO) was developed to identify the critical risk factors for distinguishing stage 2 and DTI patients

Results:

A total of 244 patients developed a stage 2 or DTI HAPrI during the study period. Of those, 38 patients with medical device-related PrI were excluded. The final study sample consisted 206 patients (n=146 stage 2, and n=60 DTI). The multivariate model showed patients who developed Stage 2 HAPrI had longer length of stay in the ICU than those with DTI (OR= 1.001, 95% CI= 1-1.002, P=0.03) but were less likely than patients with DTI to experience a diastolic blood pressure <50mmHg (OR= 0.179, 95% CI= 0.072-0.416, P=<0.001) or receive an epinephrine infusion (OR= 0.316, 95% CI= 0.079-0.525, P=0.008).

Conclusions:

In this exploratory study, surgical and cardiovascular critical care patients with DTI PrIs were more likely than patients with stage 2 to experience low diastolic blood pressure and receive epinephrine, a potent vasopressor. Future research is needed to elucidate etiologic differences between stages, which will lead to identifying effective preventive interventions Clinical Trial: N/A


 Citation

Please cite as:

Alderden J, Amoafo L, Zhang Y, Fife C, Yap D, Yap T

Comparing Risk Profiles in Critical Care Patients With Stage 2 and Deep Tissue Pressure Injuries: Exploratory Retrospective Cohort Study

JMIR Dermatol 2021;4(2):e29757

DOI: 10.2196/29757

PMID: 37632818

PMCID: 10334951

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.